Literature DB >> 8158134

Growth of ectopic dendrites on cortical pyramidal neurons in neuronal storage diseases correlates with abnormal accumulation of GM2 ganglioside.

D A Siegel1, S U Walkley.   

Abstract

Ganglioside analysis and quantitative Golgi studies of the cerebral cortex of cats with ganglioside and nonganglioside lysosomal storage diseases reveal a correlation between the amount of accumulated GM2 ganglioside and the extent of ectopic dendrite growth on cortical pyramidal neurons. This correlation was not observed with any of the other gangliosides assayed for, including GM1 ganglioside. These results suggest a specific role for GM2 ganglioside in the initiation of ectopic neurites on pyramidal cells in vivo and are consistent with the developing hypothesis that different gangliosides have specific roles in different cell types dependent upon the receptor or other effector molecules with which they may interact.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8158134     DOI: 10.1046/j.1471-4159.1994.62051852.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

Review 1.  Current controversies in Niemann-Pick C1 disease: steroids or gangliosides; neurons or neurons and glia.

Authors:  Robert P Erickson
Journal:  J Appl Genet       Date:  2013-01-05       Impact factor: 3.240

2.  Secondary storage of dermatan sulfate in Sanfilippo disease.

Authors:  William C Lamanna; Roger Lawrence; Stéphane Sarrazin; Jeffrey D Esko
Journal:  J Biol Chem       Date:  2010-12-30       Impact factor: 5.157

3.  GM2 ganglioside regulates the function of ciliary neurotrophic factor receptor in murine immortalized motor neuron-like cells (NSC-34).

Authors:  S Usuki; J Ren; I Utsunomiya; N R Cashman; J Inokuchi; T Miyatake
Journal:  Neurochem Res       Date:  2001-04       Impact factor: 3.996

4.  Lysosomal compromise and brain dysfunction: examining the role of neuroaxonal dystrophy.

Authors:  Steven U Walkley; Jakub Sikora; Matthew Micsenyi; Cristin Davidson; Kostantin Dobrenis
Journal:  Biochem Soc Trans       Date:  2010-12       Impact factor: 5.407

Review 5.  Gene therapy for lysosomal storage diseases (LSDs) in large animal models.

Authors:  Mark Haskins
Journal:  ILAR J       Date:  2009

Review 6.  GM2 ganglioside and pyramidal neuron dendritogenesis.

Authors:  S U Walkley; D A Siegel; K Dobrenis
Journal:  Neurochem Res       Date:  1995-11       Impact factor: 3.996

7.  Correlation of MR imaging and MR spectroscopy findings with cognitive impairment in mucopolysaccharidosis II.

Authors:  L Vedolin; I V D Schwartz; M Komlos; A Schuch; A C Puga; L L C Pinto; A P Pires; R Giugliani
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825

8.  Pathobiology of Christianson syndrome: Linking disrupted endosomal-lysosomal function with intellectual disability and sensory impairments.

Authors:  Mallory Kerner-Rossi; Maria Gulinello; Steven Walkley; Kostantin Dobrenis
Journal:  Neurobiol Learn Mem       Date:  2018-05-14       Impact factor: 2.877

Review 9.  Secondary lipid accumulation in lysosomal disease.

Authors:  Steven U Walkley; Marie T Vanier
Journal:  Biochim Biophys Acta       Date:  2008-12-09

Review 10.  Neurobiology and cellular pathogenesis of glycolipid storage diseases.

Authors:  Steven U Walkley
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2003-05-29       Impact factor: 6.237

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.